PronirasReviewed >4,000OpportunitiesScientists&TechnologyDevelopersSyndicationJanLundberg,Ph.D.ScientificExpertisePetraPharmaLydianNeurosciences2014 Top-quartileRankedSteveGillis,Ph.D.WuXiPharmaTechApogenBiotechnologiesTheRockefellerUniversityTachiYamada,M.D.DanaFarberCancerHarvardMedicalSchoolhigh-quality,cutting edgelife sciencecompaniesEmployeesUTSouthwesternLodoTherapeutics58.43%IRRCapital-efficiencyDivestituresSeattleOffice150+Years’ExperienceWeillCornellMedicineRodeoTherapeuticsAI &MachineLearningDiversityEliLillyTurn-KeyFacilitiesOperatingPartners?UTSouthwesternMedicalCenter$3.375BillionExitWeillCornellMedicineGatesFoundationColumbiaUniversityStrategicPartnershipsFund Inet IRRof 58.4%1.02DPIAcademic&ResearchInstitutionsUniformedServicesUniversityOncologyTemasekExceptionalTrackRecordTargetedTherapeutic(Asset)FinancingLewisCantleyNon-DilutiveFunding$1 BillionGenentechCollaborationSundarKodiyalamCorporateSpinoutsARCHVenturePartnersCPRITAdvisory&CorporateBoards(BARDA)– onupdatedslide deckCaseWesternReserve$12.3MillionNIDAGrantSyndicationPartnersMDAndersonCancerCenterPfizerVenturesRodeoTherapeuticsGatesFoundationNewYorkOfficeTop-tierInvestorsTheRockefellerUniversityCSABMembers?MagnoliaNeurosciencesInfectiousDisease,Oncology,MicrobiomeAlexandriaVentureInvestmentsEntrepreneursUniversityofMinnesotaSingaporeOfficeAbbvieBruceL.A.Carter,Ph.D.VentureCapitalWRFCapitalNeuroscience& NeurologyPennStateSubstantialExitHistoryLodoTherapeutics2.85DVPILeroyHood,M.D.,Ph.D.SanDiegoOfficeGeneYeo,Ph.D.PronirasReviewed >4,000OpportunitiesScientists&TechnologyDevelopersSyndicationJanLundberg,Ph.D.ScientificExpertisePetraPharmaLydianNeurosciences2014 Top-quartileRankedSteveGillis,Ph.D.WuXiPharmaTechApogenBiotechnologiesTheRockefellerUniversityTachiYamada,M.D.DanaFarberCancerHarvardMedicalSchoolhigh-quality,cutting edgelife sciencecompaniesEmployeesUTSouthwesternLodoTherapeutics58.43%IRRCapital-efficiencyDivestituresSeattleOffice150+Years’ExperienceWeillCornellMedicineRodeoTherapeuticsAI &MachineLearningDiversityEliLillyTurn-KeyFacilitiesOperatingPartners?UTSouthwesternMedicalCenter$3.375BillionExitWeillCornellMedicineGatesFoundationColumbiaUniversityStrategicPartnershipsFund Inet IRRof 58.4%1.02DPIAcademic&ResearchInstitutionsUniformedServicesUniversityOncologyTemasekExceptionalTrackRecordTargetedTherapeutic(Asset)FinancingLewisCantleyNon-DilutiveFunding$1 BillionGenentechCollaborationSundarKodiyalamCorporateSpinoutsARCHVenturePartnersCPRITAdvisory&CorporateBoards(BARDA)– onupdatedslide deckCaseWesternReserve$12.3MillionNIDAGrantSyndicationPartnersMDAndersonCancerCenterPfizerVenturesRodeoTherapeuticsGatesFoundationNewYorkOfficeTop-tierInvestorsTheRockefellerUniversityCSABMembers?MagnoliaNeurosciencesInfectiousDisease,Oncology,MicrobiomeAlexandriaVentureInvestmentsEntrepreneursUniversityofMinnesotaSingaporeOfficeAbbvieBruceL.A.Carter,Ph.D.VentureCapitalWRFCapitalNeuroscience& NeurologyPennStateSubstantialExitHistoryLodoTherapeutics2.85DVPILeroyHood,M.D.,Ph.D.SanDiegoOfficeGeneYeo,Ph.D.

Home for the Holidays (& everyday) - Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
  1. Proniras
  2. Reviewed > 4,000 Opportunities
  3. Scientists & Technology Developers
  4. Syndication
  5. Jan Lundberg, Ph.D.
  6. Scientific Expertise
  7. Petra Pharma
  8. Lydian Neurosciences
  9. 2014 Top-quartile Ranked
  10. Steve Gillis, Ph.D.
  11. WuXi PharmaTech
  12. Apogen Biotechnologies
  13. The Rockefeller University
  14. Tachi Yamada, M.D.
  15. Dana Farber Cancer
  16. Harvard Medical School
  17. high-quality, cutting edge life science companies
  18. Employees
  19. UT Southwestern
  20. Lodo Therapeutics
  21. 58.43% IRR
  22. Capital-efficiency
  23. Divestitures
  24. Seattle Office
  25. 150+ Years’ Experience
  26. Weill Cornell Medicine
  27. Rodeo Therapeutics
  28. AI & Machine Learning
  29. Diversity
  30. Eli Lilly
  31. Turn-Key Facilities
  32. Operating Partners?
  33. UT Southwestern Medical Center
  34. $3.375 Billion Exit
  35. Weill Cornell Medicine
  36. Gates Foundation
  37. Columbia University
  38. Strategic Partnerships
  39. Fund I net IRR of 58.4%
  40. 1.02 DPI
  41. Academic & Research Institutions
  42. Uniformed Services University
  43. Oncology
  44. Temasek
  45. Exceptional Track Record
  46. Targeted Therapeutic (Asset) Financing
  47. Lewis Cantley
  48. Non-Dilutive Funding
  49. $1 Billion Genentech Collaboration
  50. Sundar Kodiyalam
  51. Corporate Spinouts
  52. ARCH Venture Partners
  53. CPRIT
  54. Advisory & Corporate Boards
  55. (BARDA) – on updated slide deck
  56. Case Western Reserve
  57. $12.3 Million NIDA Grant
  58. Syndication Partners
  59. MD Anderson Cancer Center
  60. Pfizer Ventures
  61. Rodeo Therapeutics
  62. Gates Foundation
  63. New York Office
  64. Top-tier Investors
  65. The Rockefeller University
  66. CSAB Members?
  67. Magnolia Neurosciences
  68. Infectious Disease, Oncology, Microbiome
  69. Alexandria Venture Investments
  70. Entrepreneurs
  71. University of Minnesota
  72. Singapore Office
  73. Abbvie
  74. Bruce L.A. Carter, Ph.D.
  75. Venture Capital
  76. WRF Capital
  77. Neuroscience & Neurology
  78. Penn State
  79. Substantial Exit History
  80. Lodo Therapeutics
  81. 2.85 DVPI
  82. Leroy Hood, M.D., Ph.D.
  83. San Diego Office
  84. Gene Yeo, Ph.D.